Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.

被引：6

作者：

Peters, Katherine B. ^{[1
]}

Archer, Gerald E. ^{[1
]}

Norberg, Pamela ^{[1
]}

Xie, Weihua ^{[1
]}

Threatt, Stevie ^{[1
]}

Lipp, Eric S. ^{[1
]}

Herndon, James Emmett ^{[1
]}

Healy, Patrick ^{[1
]}

Congdon, Kendra ^{[1
]}

Sanchez-Perez, Luis ^{[1
]}

Friedman, Henry S. ^{[1
]}

Desjardins, Annick ^{[1
]}

Vlahovic, Gordana ^{[1
]}

Sampson, John H. ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.e13526

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e13526

引用

页数：1

共 50 条

[21] Ascending dose trials of the safety and tolerability of Toca 511, a retroviral replicating vector encoding cytosine deaminase, in patients with recurrent high-grade glioma.
Pertschuk, Daniel
Cloughesy, Timothy Francis
Chang, Susan Marina
Aghi, Manish K.
Vogelbaum, Michael A.
Liau, Linda M.
Shafa, Bob B.
Yong, William H.
Chen, Clark
Kesari, Santosh
Ibanez, Carlos E.
Perez, Omar D.
Robbins, Joan M.
Jolly, Douglas J.
Gruber, Harry E.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[22] Anlotinib alone or in combination with temozolomide in recurrent high-grade glioma: A retrospective study.
Yang, Qun-ying
Guo, Cheng-Cheng
He, Zhenqiang
Lin, Fuhua
Zhang, Ji
Guo, Xiaoyu
Chen, Yinsheng
Jiang, Xiaobing
Ke, Chao
Chen, Zhongping
Mou, Yonggao
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[23] Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
Yang, Qunying
Guo, Chengcheng
Lin, Xiaoping
Luo, Lili
He, Zhenqiang
Lin, Fuhua
Zhang, Ji
Chen, Yinsheng
Jiang, Xiaobing
Ke, Chao
Mou, Yonggao
FRONTIERS IN PHARMACOLOGY, 2021, 12
[24] Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
Garg, Abhishek D.
Vandenberk, Lien
Koks, Carolien
Verschuere, Tina
Boon, Louis
Van Gool, Stefaan W.
Agostinis, Patrizia
SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (328)
[25] The efficacy and safety of CyberKnife combined with bevacizumab and temozolomide in the treatment of recurrent high-grade glioma
Jingbo, K.
ANNALS OF ONCOLOGY, 2020, 31 : S402 - S402
[26] STEREOTACTIC RADIOSURGERY (SRS) IN RECURRENT HIGH-GRADE GLIOMA
Bockstein, Felix
Blumenthal, Deborah T.
Corn, BenjaminW.
Gez, Elijahu
Matceyevsky, Diana
Kanner, Andrew A.
NEURO-ONCOLOGY, 2014, 16
[27] CARBOPLATIN CHEMOTHERAPY IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
Kaloshi, G.
Rroji, A.
Petrela, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 605 - 605
[28] PRELIMINARY RESULTS OF BINIMETINIB AND ENCORAFENIB IN ADULTS WITH RECURRENT BRAF V600E-MUTATED HIGH-GRADE GLIOMA.
Schreck, Karisa
Strowd, Roy
Nabors, L. Burt
Ellingson, Ben
Fisher, Joy
Desideri, Serena
Danda, Neeraja
Rudek, Michelle
Grossman, Stuart
Ye, Xiaobu
NEURO-ONCOLOGY, 2022, 24 : 86 - 86
[29] Stereotactic Radiation Treatment in Recurrent High-grade Glioma
Abazeed, M.
Niemierko, A.
Abazeed, A.
Loefller, J. S.
Oh, K.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S277 - S277
[30] Recurrent high-grade glioma: a diagnostic and therapeutic challenge
Walbert, Tobias
Mikkelsen, Tom
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 509 - 518

← 1 2 3 4 5 →